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Abstract
Backgrounds: Health-care workers’ (HCWs) exposure to bodily fluids puts them at risk of hepatitis B virus HBV
infection. This study investigated HBV vaccination practices and outcomes in HCWs and assessed postvaccination
seroprotection across HCWs in different departments.
Methods: A survey of HCWs in a Chinese public general hospital was carried out with a retrospective cohort of
1420 hospital HCWs (458 males and 962 females). HBV vaccination status (10-μg/dose used) was investigated in the
cohort from vaccination records from the period of 1988 to 2008. Blood samples were collected and tested for
hepatitis B surface antigen (HBsAg) and HBV antibodies (anti-HBs).
Results: The overall vaccination (complete course) and HBsAg carrier rates among HCWs were 40.42 % (574/1420)
and 6.13 % (87/1420), respectively. Vaccination rates differed by department, with HCWs in internal medicine
(39.5 %) and emergency (42.0 %) departments having particularly low rates. The natural infection rate was 7.53 %
(107/1420) among HCWs. HCWs in the department of infectious diseases (vaccination rate, 57.8 %) had the highest
rate of antibody produced by natural infection (88.2 %).
Conclusion: The vaccination rate was a disappointingly low among HCWs in Pearl River Delta Area of China. HCWs
working in infectious diseases departments and technicians were at particularly likely to have been infected with
HBV. A concerted effort is needed to bring vaccination rates up among Chinese HCWs in Pearl River Delta Area of
southern China.
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Background
Hepatitis B virus (HBV) infection is a major cause of
acute and chronic liver disease worldwide [1]—including
hepatitis, cirrhosis, and hepatocellular carcinoma—and
is one of the ten most common causes of death world-
wide [2]. Approximately 30 % of the world’s population
have serologic evidence of prior HBV infection [3]. An
estimated 400 million people are infected with HBV, in-
cluding 350 million chronic cases, with at least 1 million
dying each year from chronic liver disease [4]. Chronic
HBV infection is endemic in Asia and Africa, with more
than 75 % of the world’s chronic HBsAg carriers being
of Asian or African origin [5, 6].
Vaccination of health care workers (HCWs) is particu-
larly important given their risk of exposure to blood-
borne viral infections, particularly HBV, hepatitis C virus
(HCV), and HIV, and vaccine-preventable diseases [7–9].
These risks are further heightened in developing countries
in endemic regions such as Africa and Asia, including
China [10]. Although effective anti-HBV vaccines have
been available for over 10 years, many HCWs remain non-
immunized against HBV [11]. Indeed HCWs, including
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those at particular risk of HBV infection, have been re-
ported to have inadequate participation in vaccination pro-
grams [12, 13]. Although HBV vaccination rates are not
satisfactory among HCWs in many countries, there was a
complete HBV vaccination coverage among Polish surgical
nurses [14].
However, currently, little is known about Chinese
HCWs knowledge of HBV risk. Therefore, the aim of
the present study was to assess HCWs’ HBV infection,
vaccination, and seroprotection rates. The specific objec-
tives of this study were: (1) to determine the vaccination
and anti-HBV antibody statuses of HCWs in the Liver
Disease Center of Pearl River Delta Area of China in a
public teaching general hospital; (2) to compare vaccin-
ation seroprotection across hospital departments; and
(3) to assess the HBV infection rate among Pearl River
Delta Area Chinese HCWs.
Methods
Study design and ethics statement
The present study consisted of the retrospective analysis
of medical records (1988–2008), administration of a
questionnaire, and analysis of immunological blood tests.
The protocol was approved by the local medical ethics
committee of Third Affiliated Hospital, Sun Yat-Sen
University The study was performed according to the
World Medical Association Declaration of Helsinki, and.
Written informed consent was obtained from all individ-
uals included in this study. Data were entered in dupli-
cate into a computerized database and were analyzed
anonymously.
Study population
1420 HCWs (458 males and 962 females) of our retro-
spective study were assembled by recruiting HCWs from
the health examination center database (est. 1988). And
1420HCWs were recruited from the Liver Disease
Center in Pearl River Delta Area of China (820HCWs),
the People’s Hospital of Tianhe District, GuangZhou
(390HCWs) and the TianHe Maternal and Child Health
Hospital (210HCWs), respectively. All individuals whose
data are in the database have provided written informed
consent for future research and analysis of their data;
nevertheless, all included subjects also provided written
informed consent to participate in this study as well. All
of the recruited HCWs had chosen previously to have
their routine medical examinations done at the Liver
Disease Center of Pearl River Delta Area of China in a
public teaching general hospital; therefore the popula-
tion is most closely representative of Pearl River Delta
Area of China in particular. Their data were analyzed
anonymously. Vaccination status was confirmed by rou-
tine medical examination reports.
The exclusion criteria were: detailed vaccination
record lacking, declining to complete the survey ques-
tionnaire, and declining to provide written informed
consent (see Fig. 1). The final cohort consisted of
1420HCWs had a mean age of 37.72 ± 13.37 years (only
1182 HCWs ages range, 24–51 years). By age band,
there were 146 subjects ≤25 years old, 788 that were
26–39 years old, 394 that were 40–59 years old, and 92
that were ≥60 years old.
Data collection
Questionnaire and medical records analysis
HCWs were asked to complete a questionnaire that asked
about their vaccination history, department of employ-
ment, job category, and demographics. Prior completion
of an HBV vaccination course was determined conclu-
sively by examining the participants’ medical records.
Medical examination
During their 2008 routine medical examination, all HCWs
in this study were subjected to testing for HBV serology,
including tests for hepatitis B surface antigen (HBsAg),
hepatitis surface antigen antibodies (anti-HBs), and anti-
body to hepatitis core antigen antibody (anti-HBc) tests.
The presence of HBsAg was interpreted as indicating an
active HBV infection. The presence of anti-HBs (with
anti-HBc positivity) and no prior vaccination was inter-
preted as indicating a history of HBV infection. The
presence of anti-HBs (with anti-HBc positivity) and prior
vaccination was interpreted as indicating history of HBV
infection in vaccinated successfully individuals. The pres-
ence of anti-HBs, but not anti-HBc, and a history of
vaccination was interpreted as indicating an effective vac-
cination and never having been infected with HBV. The
presence of anti-HBs (without anti-HBc positivity) was
interpreted as indicating history of vaccinated successfully
individuals.
The presence of HBsAg, anti-HBs, and anti-HBc was
determined by enzyme-linked immunosorbent assay
(ELISA) with kits from Shanghai Industrial Division Bio-
technology Limited (China). The assays were conducted
in strict accordance with the kit manufacturer’s instruc-
tions. The simple, rapid ELISA for HBsAg used is the
gold-standard method for the detection of HBsAg with
high sensitivity and specificity (≥99.0 %) [15]. The anti-
HB titer cutoff for positive response (development of
protective titers) was ≥10 mIU/mL. Data from earlier
years that were originally reported with other units were
converted to mIU/mL. All ELISAs were carried out in
duplicate.
Data analysis
Normality of datasets was determined using the Student’s
t-Test. For normally distributed data, means and standard
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deviations (SDs) were calculated and frequency distribu-
tions across category bins were determined. For non-
normally distributed data and ranges were calculated. We
used the chi-square test to detect general associations. All
tests were two-sided and p < .05 being regarded as signifi-
cant. Data were analyzed using SAS statistics software.
Results
HBV infection status
Of the 1420 participants whose data were examined, 87
(6.13 %) were found to be positive for HBsAg and thus
identified as being currently infected with HBV. As shown
in Table 1, non-vaccinated HCWs were more likely to be
HBsAg-positive (indicating an active infection), than were
vaccinated HCWs. Table 2 revealed that of the 1420 par-
ticipants, 7.53 % (107/182) had gained immunity through
natural infection with HBV.
Status of hepatitis B vaccination
The overall rate of vaccination (10-μg dose HBV
vaccine) among HCWs was 40.42 % (574/1420). Vaccin-
ation rates were similar between males and females
(Table 1). Likelihood of vaccination differed across hos-
pital departments (Table 1). HCWs in the obstetrics and
gynecology (ob/gyn) and surgery departments had the
highest rates of HBV vaccination (≥60 %), whereas
HCWs in the internal medicine and emergency depart-
ments had the lowest vaccination rates (≤42 %). HCWs
in younger age bands, particularly the ≤25 year-old
group, were more likely to have been vaccinated than
HCWs than older age bands (Table 1).
Immunity from vaccination versus natural infection
The vaccinated group was confirmed to more likely to
be anti-HBs positive (i.e. protected) than the non-
vaccinated group (Table 1). Of the 614 HCWs whose
survey results and medical histories indicated a history
of HBV vaccination, 485 (79.0 %) were found to be anti-
HBs positive. The remaining 129 HCWs (21.0 %) had no
protective anti-HBs despite their history of vaccination.
Conversely, of the 187 HCWs who had not been vacci-
nated, 76 (40.6 %) were positive for anti-HBs, indicating
prior exposure to the virus.
Overall, more HCWs in the present study gained sero-
protection against HBV from prior infection than from
vaccination. The presence of seroprotection being con-
ferred by vaccination versus natural HBV exposure
differed across departments and professions. As shown
in Table 2, HCWs working in infectious diseases depart-
ments were the most likely to have gained immunity
through prior exposure, as opposed to vaccination.
Meanwhile, medical doctors were more likely than tech-
nicans and nurses to have gained protection through
vaccination (Table 2).
Discussion
The present study demonstrated that HCWs in southern
China, overall, had a disappointingly low rate of HBV
vaccination (near 40 %). Furthermore, approximately one-
fifth of vaccinated HCWs lacked serological evidence of
protection. Vaccination rates differed in relation to HCWs’
department of employment and profession.
HBV can be transmitted by blood transfusion, injec-
tion [16], operation, dental treatment [12], needle stick
Fig. 1 A flow diagram of study participants
Zheng et al. BMC Infectious Diseases  (2015) 15:542 Page 3 of 7
injuries, and mother-to-child vertical transmission. Esti-
mates of the rate of HBV infection of HCWs following a
one-time needle prick with an HBV-exposed needle
range widely from 6 to 30 % [3]. HCWs work long hours
in high-demand environments and are exposed fre-
quently to patients’ bodily fluids, including blood, secre-
tions, and excretions. The potential risk of acquiring
blood-borne viruses through needle stick injuries has led
several authors to examine the prevention of such inci-
dents [13, 17]. Many reports have indicated that the
main and, probably, only effective mechanism of
preventing HBV infection among HCWs is an effective
vaccine, which has been in use for about two decades
[18, 19]. In 1991, the World Health Organization recom-
mended that all countries should implement an anti-
HBV vaccine in their national vaccination program by
1997 [20, 21]. Given HCWs elevated risk of HBV infec-
tion, and the related risks of infected HCWs transmitting
the virus to uninfected patients, the strength of occupa-
tional protection of HCWs by vaccination should be in-
creased aggressively [22].
The HBsAg positive rate found for HCWs in Pearl
River Delta Area of southern China in this study was
lower than expected [23]. However HCWs working in
infectious diseases departments and technicians were at
particularly likely to have been infected with HBV. Some
portion of people who receive HBV vaccine inoculation
remain at risk of HBV infection. Prior work suggests
that HBV vaccination efficacy is better in younger recipi-
ents [24]. Eight vaccinated HCWs in the present study
were HBsAg-positive, indicating that they were har-
boring an active HBV infection despite having been
inoculated; presumably, they did not produce sufficient
(or any) protective antibodies in response to the vaccine.
Hence, serum anti-HBs levels should be assayed post-
vaccination to confirm whether protection has been
Table 1 Status of HBV vaccination in HCWs in Pearl River Delta Area of China (N = 1420)
Factor Number HBV vaccination status, N (%) χ2 P
Vaccinated Not vaccinated
Sex Male 458 140 (30.57 %) 33 (7.20 %) 0.4164 .5188
Female 962 278 (28.90 %) 73 (7.59 %)
Age band <25 years 146 77 (52.7 %) 14 (7.1 %) 36.546 5.741E-08
25 ~ 39 years 788 403 (51.1 %) 106 (13.5 %)
40 ~ 59 years 394 92 (23.4 %) 62 (15.7 %)
≥60 years 92 2 (2.2 %) 0 (0.0 %)
HBsAg Detected 87 8 (1.33 %) 79 (9.65 %) 71.583 2.659E-17
Not detected 1333 593 (98.66 %) 138 (90.35 %)
Anti-HBs level <10 mIU/mL 644 285 (44.3 %) 75 (11.7 %) 11.772 0.00278
1–10 mIU/mL 326 133 (40.8 %) 31 (9.5 %)
Anti-HBc-total Not detected 450 129 (28.7 %) 62 (13.8 %)
Positive 262 42 (6.99 %) 220 (26.86 %) 5.783 3.871E-5
Negative 1158 559 (93.01 %) 599 (73.14 %)
Department Infectious diseases 106 61 (57.8 %) 17 (15.6 %) 20.660 0.0081
General medicine 367 145 (39.5 %) 71 (19.4 %)
Surgery 305 186 (60.9 %) 40 (13.1 %)
Ob/gyn 88 56 (63.6 %) 20 (22.7 %)
Pediatrics 56 33 (58.9 %) 8 (14.3 %)
Dentistry 44 22 (50.0 %) 9 (20.5 %)
Emergency 88 37 (42.0 %) 6 (6.8 %)
Nephrology 23 13 (56.5 %) 2 (8.7 %)
Other 343 48 (14.0 %) 9 (2.6 %)
Profession Medical doctor 405 194 (47.9 %) 58 (14.3 %) 3.4387 0.4873
Dentist 18 14 (77.8 %) 4 (22.2 %)
Nurse 542 311 (57.4 %) 98 (18.1 %)
Technician 123 42 (34.1 %) 17 (13.8 %)
Other 332 51 (15.4 %) 9 (2.7 %)
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conferred. The presence of protective antibodies in some
non-vaccinated HCWs was presumably due to prior nat-
ural exposure to the virus. Nevertheless, HCWs in the
vaccinated group were less likely to have a current HBV
infection (indicated by HBsAg positivity) than HCWs in
the non-vaccinated group, indicating that HBV vaccin-
ation had been clinically meaningful, though it was not
100 % effective.
Interestingly, the rate of workers having serologically
evident protection by natural infection versus vaccin-
ation was not uniform across departments. HCWs in the
infectious diseases department had the highest rate of
antibody produced by natural infection; indeed more
HCWs working in infectious diseases departments were
infected with HBV naturally than were vaccinated. It is
expected that HCWs who work in infectious diseases
departments, and thus work directly with hepatitis-
infected patients and samples, have a high risk of HBV
exposure. Hence, the low rates of vaccination among
these HCWs indicate strongly that there is a need for
greater awareness of transmission risk and for promo-
tion of HCW vaccination.
The relatively higher rate of vaccination among ob/gyn
HCWs observed in this study could be related to these
HCWs having gained greater awareness of the HBV
vaccine as a consequence of their involvement with
infant immunization plans. The four HCWs working in
hemodialysis departments (encompassed in “Other” in
Table 2), an area of particularly high infection risk [23],
were noteworthy for characteristically obtaining anti-
HBs by way of vaccination, indicating that they have a
particularly high awareness of their occupational need
for protection. It is noteworthy that immunity source
also differed in relation to profession. Technicians with
anti-HBs antibodies obtained immunity mostly through
natural infection, whereas medical doctors with anti-
HBs antibodies obtained immunity more often through
vaccination. The low vaccination protection rate of tech-
nicians is particularly concerning given their frequent
exposure to patients’ bodily fluids [25].
It is our view that HCWs who have a reasonable
expectation of being exposed to blood on the job should
be offered the HBV vaccine as a matter of course.
Furthermore, HCWs should be informed that vaccination
is not always effective and serological testing should be
performed to confirm vaccine effectiveness. HCWs should
be counseled regarding what steps they should take to pro-
tect their health in cases of vaccine non-responsiveness.
This study has the limitation of being largely limited to
enrollment of HCWs in Pearl River Delta Area of southern
China. So the HCWs enrolled in the present study can
represent Local area of the HCWs in the Pearl River Delta
Area of China to a certain extent. This geographical
limitation limits the generalizability of these findings.
Additional studies involving HCWs in other regions are
needed to determine whether the patterns of data observed
here are common southern China, throughout China and
Asia at large, and larger retrospective studies are needed to
Table 2 Protective antibody status in relation to exposure route through natural infection versus vaccination by hospital
department of employment and profession
Factor Number Portion of group with detectable protective antibodies, ratio (%) χ2 P
Vaccinated Infected naturally
N = 601 N = 107
Department Infectious diseases 106 42/61 (68.8 %) 15/17 (88.2 %) 1.743656 .0406
General medicine 367 80/145 (55.2 %) 44/71 (62.0 %) 0.927921 .1767
Surgery 305 104/186 (55.9 %) 25/40 (62.5 %) 0.695803 .2433
Ob/gyn 88 34/56 (60.7 %) 5/20 (25.0 %) −2.74299 .0030
Pediatrics 56 24/33 (72.7 %) 3/8 (37.5 %) −1.82574 .0339
Dentistry 44 12/22 (54.5 %) 5/9 (55.6 %) 0.051297 .4795
Emergency 88 23/37 (62.2 %) 3/6 (50.0 %) −0.56521 .2860
Nephrology 23 4/13 (30.8 %) 0/2 (0.0 %) −1.09545 .1367
Other 343 33/48 (68.8 %) 7/9 (77.7 %) 0.322184 .3737
Profession Doctor 405 151 (77.8 %) 27 (46.6 %) −4.68522 2E-6
Dentist 18 8 (57.1 %) 1 (25.0 %) −1.13389 .1284
Nurse 542 192 (61.7 %) 60 (61.2 %) −0.09085 .4638
Technician 123 17 (40.5 %) 12 (70.6 %) 2.095346 .0181
Other 332 31 (60.8 %) 7 (77.78 %) 0.334633 .3690
vaccination coverage/
Infected naturally rates
1420 42.32 % 7.53 % −6.35622 2E-7
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confirm the present results. There ere also the limitation of
the publication delay due to the delay in preparing the
manuscript and the submission.
Conclusion
HCWs are at an elevated risk of HBV infection due
to their exposure to blood and other bodily fluids in
the course of their work. Vaccination rates are disap-
pointingly low among HCWs in southern China, with
large portions of HCWs, especially HCWs working in
infectious diseases departments, showing serological
evidence of a natural infection history. HCWs should
not only be more broadly encouraged to be vacci-
nated, they should be made aware that a single inno-
culation may not confer protection. When HCWs
contract an HBV infection, they place coworkers and
patients at risk of infection as well. Hence, HCWs
should be vaccinated not only early, but also regularly
[26]. HCWs with undetectable or low anti-HB levels
in particular should receive booster vaccinations.
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